Stay updated on PD-L1+ NSCLC Coformulation vs Pembrolizumab Clinical Trial

Sign up to get notified when there's something new on the PD-L1+ NSCLC Coformulation vs Pembrolizumab Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the PD-L1+ NSCLC Coformulation vs Pembrolizumab Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    A minor update to the ClinicalTrials.gov page revision/version label was applied (switching from v3.5.2 to v3.5.3). This reflects a site software/version change rather than a change to the trial’s recorded information.
    Difference
    0.0%
    Check dated 2026-04-23T21:53:39.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.5.2 and no longer displays Revision: v3.5.0.
    Difference
    0.0%
    Check dated 2026-04-16T18:17:30.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    39 days ago
    Change Detected
    Summary
    A new revision entry v3.5.0 was added to the page history, and v3.4.3 is shown as a deletion.
    Difference
    0.0%
    Check dated 2026-03-18T20:24:17.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.4.3, replacing Revision: v3.4.2.
    Difference
    0.0%
    Check dated 2026-03-11T17:16:41.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    The Study Status and Recruitment Status were updated to Completed, replacing the previous Active, not recruiting status.
    Difference
    0.2%
    Check dated 2026-02-25T08:46:42.000Z thumbnail image
  7. Check
    74 days ago
    Change Detected
    Summary
    The history adds Revision: v3.4.2 and removes a government-funding/operating-status notice and Revision: v3.4.1; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-02-11T09:28:59.000Z thumbnail image

Stay in the know with updates to PD-L1+ NSCLC Coformulation vs Pembrolizumab Clinical Trial

Enter your email address, and we'll notify you when there's something new on the PD-L1+ NSCLC Coformulation vs Pembrolizumab Clinical Trial page.